Periodic Reporting for period 1 - Biventricular Epicardial Augmentation Technology (A revolutionary technology platform for providing life-saving treatment for end-stage heart failure patients)

Worldwide, there are more than 650.000 patients suffering from advanced heart failure that would profit from receiving a durable mechanical circulatory support (MCS) device. Yet in the US and Europe, only about 1,1% of these patients receive heart transplantations per year...